Media Coverage

The study was led by Vered Padler-Karavani of the Department of Cell Research and Immunology at the Shmunis School of Biomedicine and Cancer Research at TAU  (ISRAEL21c, 23.10.2020)

Novel immunotherapy extends therapy now used in fighting leukemia, Israeli researchers say (ISRAEL21c 13.10.2019)

The vaccine, developed by an Israeli researcher at TAU, has already been shown to be effective in mice - both as preventative therapy and as a cure for active disease (Channel 12 News, 1.10.2019)

Israeli research that can lead to colon cancer prevention (Channel 11 News, 24.9.2019)

Thus far the vaccine has been proven effective in mice in preventing the development of melanoma and in treating primary tumors and metastases that result from the disease (ISREAL HAYOM 6.8.2019)

Researchers discover that fat cells play key role in deadly skin cancer transformation and have come up with a way to block process (ISREAL21c 24.7.2019) Also posted in the Jerusalem Post >>

New drug stalls progression of disease for patients who have the BRCA genetic mutations, study by Sheba Medical Center with AstraZeneca and Merck shows (THE TIMES OF ISRAEL, 2.6.2019)

Cells express surface markers that help them escape most targeted therapies, TAU researchers say (TAU AMERICAN FRIENDS, 12.3.2019)

Eosinophils -disease-fighting white blood cells,  known to cause allergies and asthma might help kill cancer cells (Haaretz, 23.01.2019)


Tel Aviv University researchers say cancer-fighting skills of eosinophils, the white blood cells that are responsible for allergies, could pave way to new drugs (THE TIMES OF ISRAEL, 23.1.2019)


Dr.  Dinorah Friedmann-Morvinski a senior scientist at Tel Aviv University studies glioblastoma (brain tumors) using  mouse models that mimic the disease in humans (Ynet, 03.1.2019)


New TAU Translational Medicine Center aims to develop pharmaceuticals better, faster and for less money (The Jerusalem Post, 29.4.2018)

Prof. Noam Shomron and his team  have developed a method that will detect thousands of genetic diseases in early pregnancy by mother's blood test. The new, non-invasive test is based on an algorithm that allows the reproduction of a genome that passes out of the mother's blood and detects genetic mutations at the single gene level - with significantly higher resolution than existing tests (hayadan, 5.2.2018)


The translational medicine center is aimed at providing professional guidance for drugs developed by the university and hospitals (GLOBES, 30.1.2018)

Tel Aviv University makes every effort to respect copyright. If you own copyright to the content contained here and / or the use of such content is in your opinion infringing, Contact us as soon as possible >>
Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
UI/UX Basch_Interactive